Joshua MacAusland-Berg Amy Wiebe Radhika Marwah Katelyn Halpape
10.1080/24740527.2022.2090911
Can J Pain
2022 Aug 18;6(1):135-141.
buprenorphine/naloxone butorphanol chronic pain micro-dosing older adult
CC BY
https://pubmed.ncbi.nlm.nih.gov/36017357/
Case Reports
PMC9397438
36017357
Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report
2022